International MOU inked between chemistry and biomedical talents from Hong Kong, Singapore and Europe for late-stage cancer research enhancement.
The two research institutes in this collaboration are both located in the Hong Kong Science Park, including the LSCCB funded by the Innovation and Technology Commission’s Health@InnoHK innovation platform, and the Hong Kong Science and Technology Park Corporation partner company Invitrocue (Hong Kong). Read More (English)Read More (Traditional Chinese)Read More (Simplified Chinese) This event has …